The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age
Open accessAbstract
Abstract The utility of X-inactivation based clonality assays for evaluation of human neoplasia is well-documented. However, excessive Lyonization is a potential limitation of these assays, because it mimics clonal derivation of cells. The incidence of excessive Lyonization in healthy females is controversial, with reported incidence varying from 4% to 33%. Several explanations have been offered for the observed variation, including different criteria for excessive Lyonization, diversity of X- linked clonality assays, small population sizes and more recently, tissue specificity of X-inactivation patterns. However, it is also possible that stem cell depletion, clonal hematopoiesis, or selection pressures on blood cells results in an increased incidence of excessive skewing. If any of the latter is true, then the incidence of excessive skewing should increase with age in blood cells. To test this hypothesis, we determined X-inactivation ratios at the human androgen receptor locus of 295 normal females from three age groups: (1) neonates, (2) females 28 to 32 years old and, (3) females aged > or = 60 years. The incidence of skewing (allele ratios > or = 3:1) was 8.6% (14 of 162) in neonates (P = .104 v 28 to 32); 16.4% (11/67) in 28 to 32 y.o. (P = .0064 v > or = 60), and 37.9% (25 of 66) in women > or = 60 y.o. (P < .0001 v neonates). When a more stringent criterion for skewing was used (allele ratios > or = 10:1), the incidence was 1.9% (3 of 162) in neonates (P = .362 v 28 to 32), 4.5% (3 of 67) in 28 to 32 y.o. (P = .0022 v > or = 60), and 22.7% (15 of 66) in > or = 60 y.o. group (P < .0001 v neonates). Results have been confirmed at the phosphoglycerate kinase locus for 48 heterozygous females. The incidence of excessive skewing increases with age. In neonates, the incidence is low and may correspond to true excessive Lyonization. Acquired skewing occurs with aging in normal females and is present in 38% of females over the age of 60. Further studies are needed to determine whether acquired skewing is a consequence of stem cell depletion, true clonal hematopoiesis, growth advantage conferred by parental-specific X-chromosomes, or other causes. These data provide an explanation for variation in reported incidence of excessive skewing in normal females. Furthermore, these findings suggest that any study of clonality using X-inactivation based assays should incorporate age- matched controls for Lyonization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“during aging, blood cells are derived from fewer and fewer stem cells.”
From Aging of hematopoietic stem cells (2018) · cites this paper as [79]
In the citing paper
“However, in some elderly individuals, HSCs acquire oncogenic mutations that allow them to outcompete their neighbors and clonally expand.”
From Unraveling Hematopoiesis through the Lens of Genomics (2020) · cites this paper as Busque et al., 1996
In the citing paper
“As these HSCs clonally expand, they can account for a substantial fraction of steady state hematopoiesis, termed clonal hematopoiesis of indeterminate potential (CHIP) (Busque et al., 1996; Champion et al., 1997; Vas et al., 2012).”
From Unraveling Hematopoiesis through the Lens of Genomics (2020) · cites this paper as Busque et al., 1996
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Action in the X-chromosome of the Mouse (Mus musculus L.)
LYON, M. F. (1961) · Nature · doi:10.1038/190372a0 · Cited by 3,978
Allen, R. C., Zoghbi, H. Y., Moseley, A., Rosenblatt, H. M., & Belmont, J. W. (1992) · PubMed · Cited by 1,683
Clonal origin of chronic myelocytic leukemia in man.
Fialkow, P., Gartler, S. M., & Yoshida, A. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.4.1468 · Cited by 532
Clonal analysis using recombinant DNA probes from the X-chromosome.
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Preisinger, A. C., Willard, H. F., Michelson, A. M., Riggs, A. D., & Orkin, S. H. (1987) · PubMed · Cited by 417
Catalog Of Mutant Genes And Polymorphic Loci
Doolitile, D. P., Davisson, M. T., Guidi, J. N., & Green, M. C. (1996) · doi:10.1093/oso/9780198548690.003.0002 · Cited by 400
Glucose-6-Phosphate Dehydrogenase Mosaicism: Utilization as a Cell Marker in the Study of Leiomyomas
Linder, D., & Gartler, S. M. (1965) · Science · doi:10.1126/science.150.3692.67 · Cited by 398
Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell
Fialkow, P., Faguet, G., Jacobson, R., Vaidya, K., & Murphy, S. (1981) · Blood · doi:10.1182/blood.v58.5.916.916 · Cited by 384
Use of Restriction Fragment Length Polymorphisms to Determine the Clonal Origin of Human Tumors
Vogelstein, B., Fearon, E. R., Hamilton, S. R., & Feinberg, A. P. (1985) · Science · doi:10.1126/science.2982210 · Cited by 379
Kay, G. F., Penny, G. D., Patel, D., Ashworth, A., Brockdorff, N., & Rastan, S. (1993) · Cell · doi:10.1016/0092-8674(93)90658-d · Cited by 364
“Benign” Monoclonal Gammopathy—After 20 to 35 Years of Follow-Up
Kyle, R. A. (1993) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60015-9 · Cited by 344
Research works printed but not linked: 1
- Busque L, Gilliland DG: The PGK-PCR based clonality assay (PPCA), in Harwood AJ (ed): Methods in Molecular Biology: Proto- cols for Gene Analysis, vol 31. Totowa, NJ, Humana Press 1994, p 237
Cited by
Sorted by citations
Items 201–300 of 543
Stem Cell DNA Damage and Genome Mutation in the Context of Aging and Cancer InitiationPreprint
Zouabi, L. A., & Bardin, A. J. (2020) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a036210 · Cited by 39
Multistep tumorigenesis in peripheral T cell lymphoma
Sakata‐Yanagimoto, M. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1738-8 · Cited by 38
Machado, F. B., Machado, F. B., Faria, M. A., Lovatel, V. L., da Silva, A. F. A., Radic, C. P., Brasi, C. D. D., Rios, Á. F. L., Lopes, S. M. C. D. S., da Silveira, L. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103714 · Cited by 36
Tomkins, D. J., McDonald, H., Farrell, S. A., & Brown, C. J. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200757 · Cited by 38
Woodward, K. J., Kirtland, K. A., Dlouhy, S. R., Raskind, W. H., Bird, T. D., Malcolm, S., & Abeliovich, D. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200480 · Cited by 38
Skewed X-Chromosome Inactivation: Cause or Consequence?
Brown, C. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.304 · Cited by 38
Decoding and rejuvenating human ageing genomes: Lessons from mosaic chromosomal alterations
Dai, X., & Guo, X. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101342 · Cited by 39
Brum, I. S., Spritzer, P. M., Paris, F., Maturana, M. A., Audran, F., & Sultan, C. (2005) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2004.11.003 · Cited by 37
Lose, F. A., Duffy, D. L., Kay, G. F., Kedda, M., & Spurdle, A. B. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn345 · Cited by 37
Pathogenesis of polycythaemia vera
Hinshelwood, S., Bench, A. J., & Green, A. R. (1997) · Blood Reviews · doi:10.1016/s0268-960x(97)90021-7 · Cited by 37
Bewersdorf, J. P., Ardasheva, A., Podoltsev, N. A., Singh, A., Biancon, G., Halene, S., & Zeidan, A. M. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100587 · Cited by 37
Bone Marrow Senescence and the Microenvironment of Hematological Malignancies
Hellmich, C., Moore, J. A., Bowles, K. M., & Rushworth, S. A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00230 · Cited by 34
Genomic Aging, Clonal Hematopoiesis, and Cardiovascular Disease
Natarajan, P. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318181 · Cited by 35
Elhaji, Y. A., Gottlieb, B., Lumbroso, R., Beitel, L. K., Foulkes, W. D., Pinsky, L., & Trifiro, M. A. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1012942910375 · Cited by 35
Au, W. Y., Lam, V. M. S., Pang, A. W. K., Lee, W., Chan, J. L. C., Song, Y., Ma, E. S., & Kwong, Y.-L. (2006) · The Journals of Gerontology Series A · doi:10.1093/gerona/61.10.1086 · Cited by 35
Plenge, R. M., Tranebjærg, L., Jensen, P. K. A., Schwartz, C. E., & Willard, H. F. (1999) · The American Journal of Human Genetics · doi:10.1086/302286 · Cited by 35
Stem cell donors should not be screened for clonal hematopoiesis
Gibson, C. J., & Lindsley, R. C. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000395 · Cited by 33
Köker, M. Y., Sanal, Ö., de Boer, M., Tezcan, İ., Metìn, A., Tan, Ç., Ersoy, F., & Roos, D. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01619.x · Cited by 34
Methylation of ZNF261 as an assay for determining X chromosome inactivation patterns
Beever, C. L., Lai, B., Baldry, S. E. L., Peñaherrera, M. S., Jiang, R., Robinson, W. P., & Brown, C. J. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20045 · Cited by 34
Passenger mutations as a marker of clonal cell lineages in emerging neoplasia
Salk, J. J., & Horwitz, M. S. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.10.008 · Cited by 33
Inactivation of X-Linked Tumor Suppressor Genes in Human Cancer
Liu, R., Kain, M., & Wang, L. (2012) · Future Oncology · doi:10.2217/fon.12.26 · Cited by 34
Aging and the hemopoietic system
Pinto, A., Filippi, R. D., Frigeri, F., Corazzelli, G., & Normanno, N. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.06.006 · Cited by 34
Ayachi, S., Buscarlet, M., & Busque, L. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.008 · Cited by 32
Self-citationAging and Clonal Behavior of Hematopoietic Stem Cells
Yamashita, M., & Iwama, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23041948 · Cited by 36
Čermák, J., Beličková, M., Krejčová, H., Michalova, K., Žilovcová, S., Zemanová, Z., Březinová, J., & Sieglová, Z. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.08.008 · Cited by 33
Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1
Stevenson, D. A., Birch, P. H., Friedman, J. M., Viskochil, D. H., Balestrazzi, P., Boni, S., Buske, A., Korf, B. R., Niimura, M., Pivnick, E. K., et al. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990611)84:5 · Cited by 130
Genetic significance of skewed X‐chromosome inactivation in premature ovarian failure
Sato, K., Uehara, S., Hashiyada, M., Nabeshima, H., Sugawara, J., Terada, Y., Yaegashi, N., & Okamura, K. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30256 · Cited by 33
Kaplan, Y., Vargel, İ., Kansu, T., Akin, B., Rohmann, E., Kamaci, S., Uz, E., Özçelık, T., Wollnik, B., & Akarsu, N. A. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.128157 · Cited by 32
Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves
Nelson, K. S., & Lewis, D. B. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833bc1b0 · Cited by 32
Aging, clonal hematopoiesis and preleukemia: not just bad luck?
Shlush, L. I., Zandi, S., Itzkovitz, S., & Schuh, A. C. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1870-5 · Cited by 36
Wengler, G. S., Parolini, O., Fiorini, M., Mella, P., Smith, H. P., Ugazio, A. G., & Notarangelo, L. D. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00686-3 · Cited by 32
X chromosome inactivation in females with multiple sclerosis
Knudsen, G. P., Harbo, H. F., Smestad, C., Celius, E. G., Åkesson, E., Oturai, A. B., Ryder, L. P., Spurkland, A., & Ørstavik, K. H. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01987.x · Cited by 32
Boudewijns, M., van Dongen, J. J. M., & Langerak, A. W. (2007) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2007.060155 · Cited by 31
Lee, S. M., Choi, I. H., Lee, D. Y., Lee, H., Park, M. S., Yoo, W. J., Chung, C. Y., & Cho, T. (2012) · Journal of Orthopaedic Research® · doi:10.1002/jor.22121 · Cited by 30
Gender bias in autoimmune diseases
Knudsen, G. P. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.04.022 · Cited by 30
Shi, P. A., Hematti, P., Kalle, C. V., & Dunbar, C. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205320 · Cited by 30
Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer
Feng, Y., Yuan, Q., Newsome, R. C., Robinson, T. M., Bowman, R. L., Zuniga, A. N., Hall, K. N., Bernsten, C. M., Shabashvili, D. E., Krajcik, K. I., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230011 · Cited by 30
Somatic mutations in autoinflammatory and autoimmune disease
Torreggiani, S., Castellan, F. S., Aksentijevich, I. A., & Beck, D. B. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01168-8 · Cited by 30
Spath, M. A., Nillesen, W. M., Smits, A. P. T., Feuth, T. B., Braat, D. D. M., van Kessel, A. G., & Yntema, H. G. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33243 · Cited by 29
Mengel‐From, J., Lindahl‐Jacobsen, R., Nygaard, M., Soerensen, M., Ørstavik, K. H., Hertz, J. M., Andersen‐Ranberg, K., Tan, Q., & Christensen, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-83702-2 · Cited by 29
X‐linked thrombocytopenia in a girl
Inoue, H., Kurosawa, H., Nonoyama, S., Imai, K., Kumazaki, H., Matsunaga, T., Sato, Y., Sugita, K., & Eguchi, M. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03740.x · Cited by 29
X-chromosome Inactivation Patterns in Korean Women with Idiopathic Recurrent Spontaneous Abortion
Kim, J., Park, S.-Y., Kim, Y.-M., Kim, J.-M., Han, J. Y., & Ryu, H. (2004) · Journal of Korean Medical Science · doi:10.3346/jkms.2004.19.2.258 · Cited by 29
Acquired skewing of Lyonization remains stable for a prolonged period in healthy blood donors
van Dijk, J., Heuver, L. H. H., Stevens-Linders, E., Jansen, J., Mensink, E. J. B. M., Raymakers, R. A. P., & de Witte, T. (2002) · Leukemia · doi:10.1038/sj.leu.2402379 · Cited by 29
Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
Kjær, L. (2020) · Cancers · doi:10.3390/cancers12082100 · Cited by 30
Descriptive and Functional Genomics in Acute Myeloid Leukemia (AML): Paving the Road for a Cure
Pasquer, H., Tostain, M., Kaci, N., Roux, B., & Benajiba, L. (2021) · Cancers · doi:10.3390/cancers13040748 · Cited by 31
Murine models of clonal haematopoiesis to assess mechanisms of cardiovascular disease
Wang, Y., Sano, S., Ogawa, H., Horitani, K., Evans, M. A., Yura, Y., Miura‐Yura, E., Doviak, H., & Walsh, K. X. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab215 · Cited by 26
X‐chromosomal inactivation patterns in women with Fabry disease
Wagenhäuser, L., Rickert, V., Sommer, C., Wanner, C., Nordbeck, P., Rost, S., & Üçeyler, N. (2022) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2029 · Cited by 28
Chagnon, P., Provost, S., Bélisle, C., Bolduc, V., Gingras, M., & Busque, L. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.06.023 · Cited by 28
Self-citationBuccal swab as a reliable predictor for X inactivation ratio in inaccessible tissues
de Hoon, B., Monkhorst, K., Riegman, P. H. J., Laven, J. S. E., & Gribnau, J. H. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103194 · Cited by 28
Watson, C. M., Pelka, G. J., Radziewic, T., Shahbazian, M. D., Christodoulou, J., Williamson, S. L., & Tam, P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi191 · Cited by 27
Ishido, N., Inoue, N., Watanabe, M., Hidaka, Y., & Iwatani, Y. (2014) · Thyroid · doi:10.1089/thy.2014.0318 · Cited by 28
Harrison, C. N., & Green, A. R. (2003) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(03)00082-0 · Cited by 28
Zito, A., Roberts, A. L., Visconti, A., Rossi, N., Ejarque, R. A., Nardone, S., Moustafa, J. S. E.-S., Falchi, M., & Small, K. S. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010556 · Cited by 28
Park, S. J., & Bejar, R. L. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0133-9 · Cited by 28
Clonal Hematopoiesis and therapy related MDS/AML
Desai, P. M., & Roboz, G. J. (2019) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2019.02.006 · Cited by 28
X‐chromosome inactivation patterns in females with Prader–Willi syndrome
Butler, M. G., Theodoro, M. F., Bittel, D. C., Kuipers, P. J., Driscoll, D. J., & Talebizadeh, Z. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31506 · Cited by 27
Molecular and Trophic Mechanisms of Tumorigenesis
Levy, A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.009 · Cited by 27
Telomerase Activity In Preleukemia And Acute Myelogenous Leukemia
Li, Y., Yang, J., Andrews, C., Chen, Y., Toofanfard, P., Huang, R., Horvath, E., Chopra, H. K., Raza, A., & Preisler, H. D. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009148406 · Cited by 27
Guillén‐Navarro, E., Jiménez, R. D., Alcalde-Martín, C., Candela, R. C., Couce, M. L., Gómez, E. G., & Luengo, O. A. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-92 · Cited by 26
Biological implications of clonal hematopoiesis
Luis, T. C., Wilkinson, A. C., Beerman, I., Jaiswal, S., & Shlush, L. I. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.08.004 · Cited by 29
Kłoska, A., Jakóbkiewicz‐Banecka, J., Tylki‐Szymańska, A., Czartoryska, B., & Węgrzyn, G. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01574.x · Cited by 26
Peñaherrera, M., Barrett, I., Brown, C. J., Langlois, S., Yong, S., Lewis, M. E. S., Bruyèrè, H., Howard‐Peebles, P. N., Kalousek, D., & Robinson, W. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.580603.x · Cited by 26
von Goessel, H., Hossle, J. P., Seger, R. A., & Güngör, T. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.01.005 · Cited by 26
Allegra, A., Caserta, S., Mirabile, G., & Gangemi, S. (2023) · Cells · doi:10.3390/cells12192392 · Cited by 30
Delforge, M., Boogaerts, M., McGlave, P. B., & Verfaillie, C. M. (1999) · Blood · doi:10.1182/blood.v93.1.284 · Cited by 25
Mossner, M., Nolte, F., Hütter, G., Reins, J., Klaumuenzer, M., Nowak, V., Obländer, J., Ackermann, K., Will, S., Röhl, H., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101093 · Cited by 24
A novel quantitative targeted analysis of X-chromosome inactivation (XCI) using nanopore sequencing
Johansson, J., Lidéus, S., Höijer, I., Ameur, A., Gudmundsson, S., Annerén, G., Bondeson, M.-L., & Wilbe, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-34413-3 · Cited by 22
Cai, Y., Diao, X., Wang, S., Zhang, W., Zhang, H., & Su, Q. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.6.1379 · Cited by 23
Impact of DNA methylation programming on normal and pre-leukemic hematopoiesis
Langstein, J., Milsom, M. D., & Lipka, D. B. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.09.008 · Cited by 25
Amorós-Pérez, M., & Fuster, J. J. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.02.008 · Cited by 24
A Hypothetical‐Mathematical Model of Acute Myeloid Leukaemia Pathogenesis
Cucuianu, A., & Precup, R. (2009) · Computational and Mathematical Methods in Medicine · doi:10.1080/17486700902973751 · Cited by 23
Phenotype in X chromosome rearrangements: pitfalls of X inactivation study
Schluth‐Bolard, C., Cossée, M., Lemaire, F., Calmels, N., Dollfus, H., Jeandidier, É., & Flori, E. (2006) · Pathologie Biologie · doi:10.1016/j.patbio.2006.04.003 · Cited by 23
Shih, L., Lin, T., Dunn, P., Wu, J., Tseng, C., Lai, C., Wang, P., & Kuo, M. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(00)00649-4 · Cited by 23
Mutation Position Within Evolutionary Subclonal Architecture in AML
Welch, J. S. (2014) · Seminars in Hematology · doi:10.1053/j.seminhematol.2014.08.004 · Cited by 25
CHIPing away the progression potential of CHIP: A new reality in the making
Xie, Z., & Zeidan, A. M. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.101001 · Cited by 22
Wang, J., Xiao, Q., Chen, Y., Yi, S., Liu, D., Liu, Y., Zhang, C.-M., Wei, X., Zhou, Y.-Q., Zhong, X., et al. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.06.001 · Cited by 22
Roehl, A. C., Mußotter, T., Cooper, D. N., Kluwe, L., Wimmer, K., Högel, J., Zetzmann, M., Vogt, J., Mautner, V., & Kehrer‐Sawatzki, H. (2011) · Human Mutation · doi:10.1002/humu.22013 · Cited by 22
Aivado, M. A., Rong, A., Germing, U., Gattermann, N., Kobbe, G., Rieth, C., Haas, R. R., & Aul, C. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02302.x · Cited by 22
Somatic Mosaicism in Biology and Disease
Ogawa, H., Horitani, K., Izumiya, Y., & Sano, S. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-061121-040048 · Cited by 22
Nonrandom X Chromosome Inactivation Detection
Jones, J. R. (2014) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0907s80 · Cited by 21
Skewed X inactivation in Lesch–Nyhan disease carrier females
Torres, R. J., & Puig, J. G. (2017) · Journal of Human Genetics · doi:10.1038/jhg.2017.88 · Cited by 21
Relationship between Aging and Hematopoietic Cell Transplantation
Cupit-Link, M. C., Arora, M., Wood, W. A., & Hashmi, S. K. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.08.015 · Cited by 21
Detection of Nonrandom X Chromosome Inactivation
Thouin, M. M., Giron, J. M., & Hoffman, E. P. (2002) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0907s35 · Cited by 21
Ariga, T., Yamada, M., & Sakiyama, Y. (1997) · Pediatric Research · doi:10.1203/00006450-199704000-00013 · Cited by 21
Recent progress in the pathogenesis and management of essential thrombocythemia
Tefferi, A. (2001) · Leukemia Research · doi:10.1016/s0145-2126(00)00131-4 · Cited by 21
X-chromosome inactivation and its implications for human diseasePreprint
Gribnau, J. H., & Barakat, T. S. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/076950 · Cited by 21
Combined landscape of single-nucleotide variants and copy-number alterations in clonal hematopoiesisPreprint
Saiki, R., Momozawa, Y., Nannya, Y., Nakagawa, M. M., Ochi, Y., Yoshizato, T., Terao, C., Kuroda, Y., Shiraishi, Y., Chiba, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.05.433727 · Cited by 22
Mangaonkar, A. A., & Patnaik, M. M. (2023) · American Journal of Hematology · doi:10.1002/ajh.26915 · Cited by 20
Cannie, D., Syrris, P., Protonotarios, A., Bakalakos, A., Pruny, J., Ditaranto, R., Martínez-Veira, C., Larrañaga-Moreira, J., Medo, K., Bermúdez-Jiménez, F., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad561 · Cited by 18
Li, G., Su, Q., Liu, G.-Q., Gong, L., Zhang, W., Zhu, S.-J., Zhang, H., & Feng, Y.-M. (2006) · Oncology Reports · doi:10.3892/or.16.4.859 · Cited by 20
Clonal Hematopoiesis and Premalignant DiseasesPreprint
Kaner, J. D., Desai, P. M., Mencia-Trinchant, N., Guzmán, M. L., Roboz, G. J., & Hassane, D. C. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a035675 · Cited by 20
Immunological Aspects of X-Linked Chronic Granulomatous Disease Female Carriers
Chiriaco, M., Salfa, I., Ursu, G. M., Cifaldi, C., Cesare, S. D., Rossi, P., Matteo, G. D., & Finocchi, A. (2021) · Antioxidants · doi:10.3390/antiox10060891 · Cited by 19
Al-Abdi, S. Y., Alsaigh, A. S., Aldawoud, F. L., & Sadiq, A. A. A. (2013) · BMC Pediatrics · doi:10.1186/1471-2431-13-137 · Cited by 19
Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells
Kandarakov, O. F., & Belyavsky, A. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217902 · Cited by 22
Have humans lost control: The elusive X-controlling element
Peeters, S. B., Yang, C., & Brown, C. J. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.01.044 · Cited by 19
Severe X-linked chronic granulomatous disease in two unrelated females
Chollet‐Martin, S., Lopez, A., Gaud, C., Henry, D., Stos, B., Benna, J. E., Chedevile, G., Gendrel, D., Gougerot‐Pocidalo, M., Grandchamp, B., et al. (2006) · European Journal of Pediatrics · doi:10.1007/s00431-006-0211-3 · Cited by 19
Extrinsic and intrinsic drivers of natural killer cell clonality
Rückert, T., & Romagnani, C. (2024) · Immunological Reviews · doi:10.1111/imr.13324 · Cited by 21
Yamazaki, E., Kanamori, H., Taguchi, J., Harano, H., Mohri, H., & Okubo, T. (1997) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1997.0138 · Cited by 18
Karasawa, M., Tsukamoto, N., Yamane, A., Okamoto, K., Maehara, T., Yokohama, A., Nojima, Y., & Omine, M. (2001) · International Journal of Hematology · doi:10.1007/bf02982062 · Cited by 18
Pathogenesis of polycythaemia vera
Green, A. R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91338-0 · Cited by 18
Metadata
- Authors
- Busque, L., Mio, R., Mattioli, J., Brais, E., Blais, N., Lalonde, Y., Maragh, M., & Gilliland, D.
- Affiliations
- Hôpital Maisonneuve-Rosemont (CA)
- Research Center, Hopital Maisonneuve-Rosemont, University of Montreal, Quebec, Canada.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1996-07-01
- Volume
- 88
- Issue
- 1
- Pages
- 59-65
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W4242239767
- Cited by
- 543
- References
- 35
- Citations by year
- 2026: 12 · 2025: 21 · 2024: 21 · 2023: 24 · 2022: 29 · 2021: 29 · 2020: 24 · 2019: 29 · 2018: 30 · 2017: 22 · 2016: 17 · 2015: 12 · 2014: 16 · 2013: 7 · 2012: 11
- FWCI
- 9.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (CA47261)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- X chromosome inactivation, X-inactivation skewing, heterozygous females, stem cell depletion, clonal hematopoiesis, neonates, healthy women, blood cells, X-inactivation patterns
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Base Sequence, Clone Cells, Dosage Compensation, Genetic, Female, Heterozygote, Humans, Infant, Newborn, Methylation, Middle Aged, Models, Biological, Molecular Sequence Data, Phosphoglycerate Kinase, Transcription Factors, Polymerase Chain Reaction, Artifacts, Cell Lineage, RNA, Untranslated, RNA, Long Noncoding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review